{
    "nctId": "NCT02088710",
    "briefTitle": "Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer",
    "officialTitle": "Clinical Cohort of Individual Expectations, Side Effects, Quality of Life and Adherence in Postoperative Women With Estrogen Receptor Positive Breast Cancer During Endocrine Therapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Female Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 138,
    "primaryOutcomeMeasure": "Adverse Side Effects",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Post surgery women with estrogen receptor positive breast cancer scheduled to start first-line adjuvant endocrine therapy with Tamoxifen (+/- GnRH) or a third generation Aromatase inhibitor at the Breast Cancer Centre\n* Sufficient knowledge of German language and ability to give informed consent\n* Age of 18 and more\n\nExclusion Criteria:\n\n* Presence of a serious comorbid psychiatric condition (schizophrenia or addiction, severe depression or anxiety)\n* Presence of a life threatening comorbid medical condition",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}